DRMA Competitors & Alternatives
Compare Dermata Therapeutics Inc with similar stocks in the same industry
Biotechnology
DRMA
Main Stock$1.19
Tradestie Score
44
Market Cap
$3.50M
Analyst Upside
+236.1%
Top Competitors
226 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.71
|
$133.50M | - | 58 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$21.00
|
$110.20M | - | 57 | Compare |
|
STRO
Sutro Biopharma, Inc.
|
$28.17
|
$76.55M | - | 50 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.55
|
$71.69M | - | 56 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.74
|
$67.94M | - | 59 | Compare |
|
PALI
Palisade Bio, Inc. Common Stock
|
$1.78
|
$12.21M | 14.1 | 46 | Compare |
|
RNAZ
TransCode Therapeutics, Inc. Common Stock
|
$5.54
|
$8.85M | - | 52 | Compare |
|
ENSC
Ensysce Biosciences, Inc. Common Stock
|
$0.28
|
$7.21M | - | 52 | Compare |
|
BBLG
Bone Biologics Corp Common Stock
|
$1.38
|
$5.01M | - | 63 | Compare |
|
REVB
Revelation Biosciences, Inc. Common Stock
|
$0.96
|
$3.42M | - | 44 | Compare |
More DRMA Analysis
Data updated: Jun 17, 2026 | Industry: Biotechnology (SIC 2834)
226 stocks in this industry